E3 ubiquitin ligase Hades negatively regulates the exonuclear function of p53

Cell Death and Differentiation

Volumn 18, Issue 12, 2011, Pages 1865-1875

  Jung, J H ^a   Bae, S ^a   Lee, J Y ^a   Woo, S R ^b   Cha, H J ^a   Yoon, Y ^a   Suh, K S ^c   Lee, S J ^d   Park, I C ^b   Jin, Y W ^e   Lee, K H ^b   An, S ^a   Lee, J H ^a,f  

^a Konkuk University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Hanyang University   (South Korea)

^e Korea Hydro & Nuclear Power Co   (South Korea)

^f Catholic Kwandong University   (South Korea)

Author keywords

E3 ligase; p53; ubiquitination

Indexed keywords

LYSINE; PROTEIN BCL 2; PROTEIN HADES; PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; RING FINGER MOTIF; UBIQUITINATION;

CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; GREEN FLUORESCENT PROTEINS; HUMANS; LEUPEPTINS; MITOCHONDRIA; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STABILITY; PROTEOLYSIS; RECOMBINANT FUSION PROTEINS; RING FINGER DOMAINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 81155137759     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.57     Document Type: Article

References (35)

1. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiationinduced G1 arrest. Cell 1994; 76: 1013-1023. (Pubitemid 24106382)
2. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiationinduced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849. (Pubitemid 23132161)
3. Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358: 15-16.
4. Raycroft L, Wu HY, Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 1990; 249: 1049-1051.
5. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458: 1127-1130.
6. Wagner AJ, Kokontis JM, Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 1994; 8: 2817-2830.
7. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220-223. (Pubitemid 24236778)
8. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 1995; 9: 2170-2183.
9. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000; 275: 7337-7342. (Pubitemid 30146286)
10. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000; 275: 16202.
11. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577-590. (Pubitemid 36385115)
12. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303: 1010-1014. (Pubitemid 38209704)
13. Jiang P, Du W, Heese K, Wu M. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol 2006; 26: 9071-9082. (Pubitemid 44851962)
14. Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 2006; 281: 8600-8606. (Pubitemid 43847963)
15. Geyer RK, Yu ZK, Maki CG. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2000; 2: 569-573.
16. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 2007; 26: 923-934.
17. Marchenko ND, Moll UM. The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle 2007; 6: 1718-1723. (Pubitemid 47327924)
18. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996; 14: 430-440. (Pubitemid 26414587)
19. Nie L, Sasaki M, Maki CG. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J Biol Chem 2007; 282: 14616-14625. (Pubitemid 47100427)
20. Smalle J, Vierstra RD. The ubiquitin 26S proteasome proteolytic pathway. Annu Rev Plant Biol 2004; 55: 555-590. (Pubitemid 38940944)
21. Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 2000; 20: 8458-8467.
22. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429: 86-92. (Pubitemid 38620556)
23. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S et al. Pirh2, a p53-induced ubiquitinprotein ligase, promotes p53 degradation. Cell 2003; 112: 779-791. (Pubitemid 36378882)
24. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093. (Pubitemid 19169804)
25. Shaulsky G, Ben-Ze'ev A, Rotter V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 1990; 5: 1707-1711. (Pubitemid 120034693)
26. Martinez J, Georgoff I, Martinez J, Levine AJ. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 1991; 5: 151-159. (Pubitemid 21905941)
27. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 2008; 3: e1487.
28. Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA et al. Cargoselected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol 2008; 18: 102-108.
29. Braschi E, Zunino R, McBride HM. MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep 2009; 10: 748-754.
30. Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Mol Cell 2006; 21: 307-315. (Pubitemid 43163526)
31. Shirangi TR, Zaika A, Moll UM. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J 2002; 16: 420-422.
32. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005; 121: 1071-1083. (Pubitemid 40884397)
33. Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Grossman SR. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA 2009; 106: 16275-16280.
34. Woo SH, An S, Lee HC, Jin HO, Seo SK, Yoo DH et al. A truncated form of p23 downregulates telomerase activity via disruption of Hsp90 function. J Biol Chem 2009; 284: 30871-30880.
35. Jin HO, Seo SK, Woo SH, Lee HC, Kim ES, Yoo DH et al. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Lung Cancer 2008; 61: 317-327.